BioHealth News Archive
Brenda McKenzie to be named Baltimore Development Corp. president – Baltimore Business Journal
Brenda McKenzie, a high-ranking economic development official in Boston, is expected to be named on Monday as the next president of the Baltimore Development…
Read More
Startup Maryland Announces 8 Finalists for “Pitch Across MD” – myUMBC
Startup Maryland, today announced the 8 Finalist for the Pitch Across Maryland competition. After posting the 168 video pitches from Maryland entrepreneurs that were captured during…
Read More
Angels in Life Science America – Xconomy
What happens when the FDA approval process slows down and imposes higher hurdles, when cost-reduction becomes central to the healthcare provider business model, when…
Read More
Maryland Department of Business & Economic Development Annual Report 2012
Commemorating a year that positioned Maryland as a national leader in the innovation economy, DBED has released its FY 2012 Annual Report. Highlights include…
Read More
Maryland Is Nation’s 2nd Best Educated State – Baltimore Citybizlist
Maryland is the nation’s second best educated state with 36.9 percent of its population aged 25 or over holding a bachelor’s degree or higher,…
Read More
Three MD Start-Ups Tapped for $1.1M through InvestMaryland Program
As part of today’s Maryland Entrepreneur Expo 2012 hosted by TEDCO, Maryland Department of Business and Economic Development (DBED) Secretary Christian S. Johansson announced…
Read More
GlycoMimetics Addresses Fundraising in Challenging Times
On November 8, 2012, the BioPark hosted Rachel King, CEO of GlycoMimetics, as part of its Business of Bio speaker series. Ms. King spoke before…
Read More
Who Are Biotech’s New Go-To Investment Bankers? – Xconomy
Not that long ago, biotech executives weren’t sure who to call on Wall Street, or whether anyone would answer the phone. In late 2008…
Read More
Anthrax treatment developed by HGS headed for approval – Gazette.Net
GlaxoSmithKline, the new owner of Rockville's Human Genome Sciences, cleared a significant regulatory hurdle last week when a Food and Drug Administration advisory panel…
Read More
Supporting Network Infrastructure for MedImmune
MedImmune, the global biologics arm of AstraZeneca PLC operating through various affiliates in the AstraZeneca Group, has approximately 5,500 full-time employees and contractors worldwide…
Read More
MIPS 25th Anniversary Profile: MedImmune–characterization of Synagis® – Mtech Blog
Gaithersburg-based MedImmune is the global biologics arm of AstraZeneca PLC, with approximately 3,500 employees worldwide. MedImmune’s Synagis® product is the first monoclonal antibody approved…
Read More
QIAGEN Kicks Off Next-Generation Sequencing Initiative with Launch of a Series of Consumable Products to Improve NGS Workflows – SelectScience
QIAGEN N.V. has announced the first product launches in its initiative to advance routine workflows in next-generation sequencing (NGS) applications. At the annual meeting…
Read More
NextWave of Pharma Innovation? – Forbes
Medical innovation is the key to addressing the big unmet needs in neurodegeneration, metabolic and heart disease, cancer, among many other conditions. Not only…
Read More
SAIC Pulls in $242M in Healthcare Contracts; Steve Comber Comments
SAIC has won several contracts this quarter totaling approximately $242 million from the government and commercial healthcare industry, the company announced today. “This has…
Read More
Commercialization Assistance Program (CAP) For Phase II SBIR & STTR Awardees
Applications Deadline EXTENDED: November 14, 2012 Program Selection: November 21, 2012 What is CAP? The NIH Commercialization Assistance Program (CAP) is a specialized technical…
Read More